Medical Research and Clinical Trials

Everest Clinical Research Bolsters Global Biometrics Expertise with Acquisition of Firma DS

• Medical Research and Clinical Trials

Everest Clinical Research Bolsters Global Biometrics Expertise with Acquisition of Firma DS

Siti Muinah September 18, 2026

New York, NY – September 18, 2026 – In a strategic move set to significantly enhance its...

Read More Read more about Everest Clinical Research Bolsters Global Biometrics Expertise with Acquisition of Firma DS

Roche Pushes for Earlier Use of Lunsumio in Follicular Lymphoma with Promising Phase III Data

• Medical Research and Clinical Trials

Roche Pushes for Earlier Use of Lunsumio in Follicular Lymphoma with Promising Phase III Data

Nana September 18, 2026

Basel, Switzerland – [Insert Date] – Roche is actively seeking to expand the therapeutic landscape for its...

Read More Read more about Roche Pushes for Earlier Use of Lunsumio in Follicular Lymphoma with Promising Phase III Data

Cambridge Breakthrough Offers Hope: 100% Survival Rate in Aggressive Inherited Breast Cancer Trial

• Medical Research and Clinical Trials

Cambridge Breakthrough Offers Hope: 100% Survival Rate in Aggressive Inherited Breast Cancer Trial

Jia Lissa September 18, 2026

CAMBRIDGE, UK – A groundbreaking new treatment approach, pioneered by researchers at Cambridge, has delivered an unprecedented...

Read More Read more about Cambridge Breakthrough Offers Hope: 100% Survival Rate in Aggressive Inherited Breast Cancer Trial

Vera Therapeutics Poised for Full Approval of Trutakna in IgAN Following Robust Phase III Data

• Medical Research and Clinical Trials

Vera Therapeutics Poised for Full Approval of Trutakna in IgAN Following Robust Phase III Data

Evan Lee Salim September 18, 2026

London, UK – [Insert Date] – Vera Therapeutics is on the cusp of securing full FDA approval...

Read More Read more about Vera Therapeutics Poised for Full Approval of Trutakna in IgAN Following Robust Phase III Data

Revolutionary Breakthrough: Brain Tumour Diagnosis Slashed from Weeks to Hours, Transforming Patient Care

• Medical Research and Clinical Trials

Revolutionary Breakthrough: Brain Tumour Diagnosis Slashed from Weeks to Hours, Transforming Patient Care

Lina Hope September 18, 2026

Nottingham, UK – In a monumental leap for neuro-oncology, scientists and clinicians in Nottingham have unveiled a...

Read More Read more about Revolutionary Breakthrough: Brain Tumour Diagnosis Slashed from Weeks to Hours, Transforming Patient Care

SpliSense Advances Promising Cystic Fibrosis Therapy with Pivotal Phase IIb Trial Initiation

• Medical Research and Clinical Trials

SpliSense Advances Promising Cystic Fibrosis Therapy with Pivotal Phase IIb Trial Initiation

Dwi Wanna September 18, 2026

Cambridge, MA – [Insert Date of Publication] – SpliSense, a clinical-stage biopharmaceutical company, has announced the commencement...

Read More Read more about SpliSense Advances Promising Cystic Fibrosis Therapy with Pivotal Phase IIb Trial Initiation

AI-Powered Imaging Revolutionizes Early Detection of Lung Cancer Treatment Efficacy

• Medical Research and Clinical Trials

AI-Powered Imaging Revolutionizes Early Detection of Lung Cancer Treatment Efficacy

Asro September 17, 2026

Seoul, Republic of Korea – A groundbreaking artificial intelligence (AI) imaging endpoint has demonstrated a remarkable ability...

Read More Read more about AI-Powered Imaging Revolutionizes Early Detection of Lung Cancer Treatment Efficacy

A New Dawn in Cancer Immunotherapy: Mount Sinai Scientists Unveil ‘Trojan Horse’ Strategy Against Metastatic Disease

• Medical Research and Clinical Trials

A New Dawn in Cancer Immunotherapy: Mount Sinai Scientists Unveil ‘Trojan Horse’ Strategy Against Metastatic Disease

Nana Wu September 17, 2026

New York, NY – January 22, 2024 – In a significant breakthrough poised to redefine the landscape...

Read More Read more about A New Dawn in Cancer Immunotherapy: Mount Sinai Scientists Unveil ‘Trojan Horse’ Strategy Against Metastatic Disease

Groundbreaking Phase III Trial for MDMA-Assisted Therapy to Treat PTSD Launches in Canada

• Medical Research and Clinical Trials

Groundbreaking Phase III Trial for MDMA-Assisted Therapy to Treat PTSD Launches in Canada

Azzam Bilal Chamdy September 17, 2026

A significant step forward in the treatment of post-traumatic stress disorder (PTSD) is being taken in Canada...

Read More Read more about Groundbreaking Phase III Trial for MDMA-Assisted Therapy to Treat PTSD Launches in Canada

Arrowhead Pharmaceuticals Achieves Landmark Dual-Gene Silencing with ARO-DIMER-PA, Promising New Era for Cardiovascular Disease Treatment

• Medical Research and Clinical Trials

Arrowhead Pharmaceuticals Achieves Landmark Dual-Gene Silencing with ARO-DIMER-PA, Promising New Era for Cardiovascular Disease Treatment

Nana September 17, 2026

San Diego, CA – [Insert Date] – Arrowhead Pharmaceuticals has announced significant interim top-line results from its...

Read More Read more about Arrowhead Pharmaceuticals Achieves Landmark Dual-Gene Silencing with ARO-DIMER-PA, Promising New Era for Cardiovascular Disease Treatment